PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsbacterial vaginosis
MeSH D016585 - bacterial vaginosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D014627:Vaginitis
0 Companies
0 Drugs
Success rate
D001424:Bacterial infections
D016585: 
Bacterial vaginosis
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Abbott BiotherapeuticsClindamycin Clindamycin  2001-06-29   
Metronidazole Metronidazole  1983-11-18   
Able LaboratoriesMetronidazole Metronidazole  2003-06-25   
Alembic PharmaceuticalsMetronidazole Metronidazole  2009-06-23   
Clindamycin Clindamycin  2024-04-02   
AllerganClindamycin Clindamycin  1988-06-08   
Clindamycin, Benzoyl peroxide Clindamycin Benzoyl Peroxide  2015-06-19   
Clindamycin, Tretinoin Clindamycin Tretinoin  2015-06-12   
Metronidazole Metronidazole  1984-12-20   
AlmirallClindamycin, Tretinoin Veltin  2010-07-16   
Amneal PharmaceuticalsClindamycin Clindamycin  2014-03-13   
Metronidazole Metronidazole  2023-05-24   
APP PharmaceuticalsClindamycin Clindamycin  1988-06-03   
Metronidazole Metronidazole  1984-12-03   
Aurobindo PharmaClindamycin Clindamycin  2009-08-26   
Metronidazole Metronidazole  2015-05-29   
B. Braun MedicalMetronidazole Metro  1982-08-31   
Bausch Health CompaniesClindamycin, Benzoyl peroxide Benzaclin  2000-12-21   
Clindamycin Clindagel  2000-11-27   
Metronidazole Metrogel  1992-08-17   
Metronidazole Noritate  1997-09-26   
Clindamycin, Benzoyl peroxide Onexton 2029-06-03 2008-10-23   
Clindamycin, Tretinoin Ziana  2006-11-07   
Clindamycin, Adapalene, Benzoyl peroxide Cabtreo 2029-06-03 2023-10-20   
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
100%
9/9
Phase 2
80%
8/10
Phase 3
39%
13/33
Approved: 4Overall Success rate: 32%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
Allergan
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use